Our individual DRIVe programs accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats. We push the boundaries of innovation to tackle the biggest health security challenges.
Enhance the usability of 3D human tissue models (“tissue chips”) as tools for drug development.
Read MoreUse pathogen-agnostic technologies from the ENACT and Solving Sepsis portfolios in response to COVID-19.
Read MoreDevelop alternative delivery methods for vaccines and other therapeutics.
Seek interventions to identify sepsis early resulting in improved patient outcomes and decreased mortality.
Read MoreFirst line of defense against health threats with rapidly deployable digital tools.
Read MoreEnabling better health outcomes through biological sample testing at the point-of-care.
Read MoreHome-based, over the counter diagnostics and enabling technologies for the detection of SARS CoV-2.
Read More